Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001708599-25-000095

Chief Scientific Officer sold 5,500 shares at $5.25 ($28,875)

  • Chief Scientific Officer acquired 5,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Moreadith Randall Chief Scientific Officer 2025-08-12 Option exercise 10b5-1 +5,500 $0.06 $330 5,500 D: show line 1 in the form
Moreadith Randall Chief Scientific Officer 2025-08-12 Sale 10b5-1 −5,500 $5.25 $28,875 0 D: show line 2 in the form
Open-market sales · 5,500 sh · avg $5.25 · $28,875

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Moreadith Randall Chief Scientific Officer 2025-08-12 Option exercise · Stock Option (right to buy) 10b5-1 −5,500 473,490 D: show line 3 in the form
Loading xslF345X05/wk-form4_1755203256.xml…